Deepa Suryanarayan

[Rocky Mountain IM @RockyMtnIM]

Our Day 1 workshops are underway! We have 5 amazing presentations on a variety of topics.

Thank you Dr. Wik, Dr. Suryanarayan, Dr. Girard, Dr. Bromley, Dr. Manji, and Dr. Javed for your expertise! #RMIM23

[Deepa Suryanarayan @DeepaSurya55]

@KaraNerenberg @HeartandStroke @CanPostPregNet Way to go Kara!

[Marc Carrier @MarcCarrier1]

Great honour for Dr. @LanaCastellucci and I on behalf of the BOD to highlight Dr. Douketis’ contributions to @ThrombosisCan. From first ever funded fellow to President of our association. Thank you for all your hard work! We are truly grateful!

[Thrombosis Canada @ThrombosisCan]

World Thrombosis Day started off early in Calgary with the lighting of the Calgary Tower in recognition of #WTDay22. We're looking forward to the pictures from across the country in the next few days. Stay tuned! Thanks to @EddyLang1 for capturing this for us! #KnowThrombosis

[Deepa Suryanarayan @DeepaSurya55]

World Thrombosis Day! Enjoyed presenting at #CSIM2022 regarding special cases in thrombosis. #clottalks #WTD22 #canvector #thrombosiscanada

[Thrombosis Canada @ThrombosisCan]

Please share @Karen__Moffat @moodleyo @Matt_BloodMD @MahaOthman8 @MPaiMD
@James_Paul @katplenk @LRannelli @GuillaumeRobMD @andreroussin @Ritaselby1
@sudeeppappur @SalmaShivji @sholzberg @DebSiegal @leslieskeith @Waelsumaya
@deepasurya55 @Vtagalakis @tsengeric
@turpiea

[Marc Carrier @MarcCarrier1]

First prospective study including patients with isolated SSPE managed without anticoagulation published in @AnnalsofIM. Rate of recurrent VTE is 3.1% . Nice collaboration between @INNOVTE1 and @canvector funded by @HeartandStroke https://t.co/GdcbM1fRp1
@OttMethodsCentr

[Deepa Suryanarayan @DeepaSurya55]

@erinhelson @canvector @RockyMtnIM Good work @erinhelson

[Erin @erinhelson]

When all those research blocks and help from @canvector lead to some interesting data. Check out our work at #RMIM21 posters @RockyMtnIM @DeepaSurya55

[Deepa Suryanarayan @DeepaSurya55]

@sholzberg @MaryCushmanMD @aswolberg @RPTHjournal Congratulations Michelle!

[Deepa Suryanarayan @DeepaSurya55]

@KaraNerenberg @HTNCanada Awesome job and so very proud of you Kara!

[Michelle Sholzberg @sholzberg]

🚨Final results of the RAPID trial now pub'd @medrxivpreprint 🚨 RAPID was an open-label trial that randomly assigned hospitalized ward patients with COVID-19 and elevated D-dimer levels to therapeutic or prophylactic heparin. 🧵 1/10 https://t.co/oxiyXQAPeK

[CBC News Alerts @CBCAlerts]

BREAKING: Health Canada authorizes the use of the Pfizer-BioNTech COVID-19 vaccine in children 12 to 15 years of age. This is the first COVID-19 vaccine authorized in Canada for use in children.

[Deepa Suryanarayan @DeepaSurya55]

Very informative, clear and balanced thread on AZ vaccine risks and benefits and how to make informed decision! Privileged to know and have worked with @MPaiMD

[Menaka Pai, MSc MD FRCPC @MPaiMD]

So you read today’s NACI advice - AZ ok if you’re 30+! Unless you can wait for mRNA 💉! And then you read the MANY hot takes from experts, non-experts, and para-experts. And you are SCARED. Let’s work through it. (The required reading is below). 1/n https://t.co/glxRy1O2V5

[ISTH @isth]

The ISTH has released interim guidance on vaccine-induced immune thrombotic thrombocytopenia (#VITT) to inform the management of suspected thrombosis in subjects who have recently received the AstraZeneca or Johnson & Johnson vaccine. https://t.co/qqtQtpywaf

[Menaka Pai, MSc MD FRCPC @MPaiMD]

Hey Ontario. Our healthcare system (and all the good things that flow from it, including the economy) is about to collapse. It's about powerful people not making hard choices that ultimately benefit everyone they are supposed to serve. What can YOU do? Empower YOURSELF. Read on:

[CTV News @CTVNews]

Blood clots may be linked to AstraZeneca vaccine but still very rare: Health Canada https://t.co/4Ri5d7vQp1

[Thrombosis Canada @ThrombosisCan]

We're pleased to announce the availability of a new Clinical Guide on Vaccine-Induced Prothrombotic Immune Thrombocytopenia (VIPIT). It can be accessed here: https://t.co/h52dfYXppj in the COVID-19 or VTE sections

[Marc Carrier @MarcCarrier1]

The @ASH_hematology 2021 guidelines on the prevention and treatment of cancer-associated thrombosis are now available! 34 recommendations to guide clinicians
https://t.co/CumVo50uBU
@ThrombosisCan @canvector

[ATTACC CAP @ATTACC_CAP]

Important announcement from ATTACC, ⁦⁦@ACTIV4a⁩ and ⁦@remap_cap⁩: Full-dose blood thinners decreased need for life support and improved outcomes in hospitalized COVID-19 patients https://t.co/2tVsALK92u